Phase III studies of triple combination of VX-445, tezacaftor and ivacaftor meet primary endpoint March 7, 2019
LGM-2605 protects from ozone-induced airway inflammation and hyperreactivity in rhesus macaques March 6, 2019
Verona reports part one data from phase II trial of DPI formulation of ensifentrine in COPD March 4, 2019
Bayer presents novel adenosine A2B receptor antagonist with potential for lung fibrosis Feb. 28, 2019
RSS